X4 Pharmaceuticals, Inc.
DEUTERATED COMPOUNDS AND USES THEREOF
Last updated:
Abstract:
The present invention provides deuterium-enriched CXCR4 inhibitors, pharmaceutical compositions, and methods of using such deuterium-enriched CXCR4 inhibitors and pharmaceutical compositions to treat, prevent, or ameliorate a disease, disorder, or condition such as cancer or WHIM syndrome.
Status:
Application
Type:
Utility
Filling date:
15 Jul 2021
Issue date:
20 Jan 2022